#Crise #Pharma #Fraude Médicaments non agréés #Diabète GlaxoSmithKline to pay $3bn in US drug fraud scandal http://t.co/wJxBWwgu0p
July 05, 2013
Publicité
/http%3A%2F%2Fnews.bbcimg.co.uk%2Fmedia%2Fimages%2F68520000%2Fjpg%2F_68520403_68520402.jpg)
GlaxoSmithKline 'guilty of fraud'
GlaxoSmithKline is to pay $3bn (£1.9bn) in the largest healthcare fraud settlement in US history. The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration (FDA).